Showing results (1371-1380 of 6,130) with videos related to

Sort By:
Pageof 613
International Journal of Antimicrobial Agents|August 3, 2024
Beware of resistance to 2nd-generation integrase inhibitors: A systematic meta-analysis of HIV-1 integrase inhibitors resistance and drug resistance mutationsShanshan Liu, Defu Yuan, Ying Zhou, et al.
International Journal of Antimicrobial Agents|August 3, 2024
Mediastinitis caused by an NDM-1 Escherichia coli in a child with Dacron Sano shunt after pulmonary atresia with ventricular septal defect surgery treated with combination of aztreonam-avibactamVladimir L Cousin, Jordi Miatello, Roberto Sierra, et al.
International Journal of Antimicrobial Agents|August 4, 2024
A metagenomics-based approach to decipher the resistome and mobilome of two seahorse species, Hippocampus barbouri and Hippocampus comesChinee S Padasas-Adalla, Rose Chinly Mae H Ortega-Kindica, Carlos O Lomelí-Ortega, et al.
International Journal of Antimicrobial Agents|August 15, 2024
Pharmacodynamics of taniborbactam in combination with cefepime studied in an in vitro model of infectionA R Noel, M Attwood, K E Bowker, et al.
International Journal of Antimicrobial Agents|August 15, 2024
Advancing research and development of anti-infectives for children with a focus on antiretroviral therapy: A clinical development perspectiveAnn M Buchanan, Adrie Bekker, Hardik Chandasana, et al.
International Journal of Antimicrobial Agents|July 31, 2024
Genomic characterisation of a multidrug-resistant Klebsiella pneumoniae co-harbouring blaNDM-1, blaKPC-2, and tet(A) isolated from the bloodstream infections of patientsZhijun Zhang, Ren Ren, Chong Peng, et al.
International Journal of Antimicrobial Agents|June 24, 2024
Within-host transition to GES-55 during a GES-6-producing Serratia marcescens outbreak: Emergence of ceftazidime-avibactam resistance and increased susceptibility to carbapenemsSergio García-Fernández, Jorge Rodríguez-Grande, María Siller-Ruiz, et al.
International Journal of Antimicrobial Agents|June 30, 2024
Factors affecting the effectiveness and safety of polymyxin B in the treatment of Gram-negative bacterial infections: A meta-analysis of 96 articlesYi-Chang Zhao, Chen-Yu Wang, Jia-Yi Liu, et al.
International Journal of Antimicrobial Agents|June 26, 2024
Resistance to aztreonam-avibactam among clinical isolates of Escherichia coli is primarily mediated by altered penicillin-binding protein 3 and impermeabilityChaitanya Tellapragada, Mohammad Razavi, Pol Saludes Peris, et al.
International Journal of Antimicrobial Agents|July 20, 2024
Q48K mutation in the type IB nitroreductase NrmA is responsible for nitrofurantoin resistance in Enterococcus faeciumPei Li, Qingqing Xu, Li Ding, et al.
Pageof 613